Exagen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
XGN Nasdaq 2836 www.exagen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Exagen Inc.

Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution - Aug 5th, 2026 10:32 pm
Exagen Inc. Q2 2026 Earnings Call Summary - Aug 4th, 2026 3:23 pm
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability - Aug 4th, 2026 3:03 pm
Exagen Q2 Earnings Call Highlights - Aug 4th, 2026 1:04 pm
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance - Aug 4th, 2026 9:28 am
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates - Aug 4th, 2026 7:20 am
Exagen Inc. Reports Second Quarter 2026 Financial Results - Aug 4th, 2026 6:00 am
Exagen Inc. to Participate in Upcoming Investor Conference - Jul 28th, 2026 7:00 am
Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Jul 21st, 2026 7:00 am
Exagen (XGN) Stock Draws Fresh Price Target Split After Analysts Trim Targets - Jun 18th, 2026 10:33 pm
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus - Jun 1st, 2026 7:00 am
How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05% - May 28th, 2026 7:55 am
The Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New Forecasts - May 14th, 2026 5:15 am
Exagen (XGN) Q1 2026 Earnings Transcript - May 12th, 2026 12:16 pm
Exagen Inc. Q1 2026 Earnings Call Summary - May 12th, 2026 6:30 am
Exagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - May 12th, 2026 1:02 am
Exagen Q1 Earnings Call Highlights - May 11th, 2026 11:09 am
Record Revenue Growth and Higher Test Pricing Keep Exagen (XGN) in Focus Despite Ongoing Losses - May 11th, 2026 8:59 am
Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates - May 11th, 2026 7:20 am
Exagen Inc. Reports First Quarter 2026 Results - May 11th, 2026 6:00 am